再鼎医药:私人配售美国存托股份净筹2.41亿美元 用于DLL3 ADC药物开发

财中社
Oct 23

10月23日,再鼎医药(09688/ZLAB)发布公告,公司于2026年10月22日与投资者签订了证券购买协议,计划通过私人配售向投资者发行和出售合共1134万股美国存托股份,代表合计面值为680.4美元的1.13亿股相关股份。每股美国存托股份的发售价格为22.04美元,相当于每股相关股份约17.28港元,较联交所于协议日期前最后交易日所报每股普通股收市价17.84港元折让约3.14%。  此次...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10